M918V RET mutation causes familial medullary thyroid carcinoma: study of 8 affected kindreds

Germline mutations in codon 918 of exon 16 of the RET gene (M918T) are classically associated with multiple endocrine neoplasia type 2B ( MEN 2B) with highly aggressive medullary thyroid cancer (MTC), pheochromocytoma and a unique phenotype. The objectives of this study are to describe the rare M918...

Descripción completa

Detalles Bibliográficos
Autores: Martins-Costa, Maria Cecilia [UNIFESP], Cunha, Lucas Leite [UNIFESP], Lindsey, Susan Chow [UNIFESP], Camacho, Cléber Pinto [UNIFESP], Dotto, Renata Pires [UNIFESP], Furuzawa, Gilberto Koiti [UNIFESP], Sousa, Maria Sharmila Alina de [UNIFESP], Kasamatsu, Teresa Sayoko [UNIFESP], Kunii, Ilda Sizue [UNIFESP], Martins, Marcio Maciel [UNIFESP], Machado, Alberto L. [UNIFESP], Martins, João Roberto Maciel [UNIFESP], Dias-da-Silva, Magnus Régios [UNIFESP], Maciel, Rui Monteiro de Barros [UNIFESP]
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2016
País:Brasil
Institución:Universidade Federal de São Paulo (UNIFESP)
Repositorio:Repositório Institucional da UNIFESP
Idioma:inglés
OAI Identifier:oai:repositorio.unifesp.br:11600/56652
Acceso en línea:http://dx.doi.org/10.1530/ERC-16-0141
https://repositorio.unifesp.br/handle/11600/56652
Access Level:acceso abierto
Palabra clave:medullary thyroid
carcinoma
RET mutation
RET M918V
founder effect
Descripción
Sumario:Germline mutations in codon 918 of exon 16 of the RET gene (M918T) are classically associated with multiple endocrine neoplasia type 2B ( MEN 2B) with highly aggressive medullary thyroid cancer (MTC), pheochromocytoma and a unique phenotype. The objectives of this study are to describe the rare M918V RET mutation discovered in 8 MTC kindreds from Brazil lacking the MEN 2B phenotype classically observed in M918T patients and to investigate the presence of a founder effect for this germline mutation. Eight apparently sporadic MTC cases were diagnosed with the germline M918V RET mutation. Subsequently, their relatives underwent clinical and genetic assessment (n = 113), and M918V was found in 42 of them. Until today, 20/50 M918V carriers underwent thyroidectomy and all presented MTC/C-cell hyperplasia